JP2002536438A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002536438A5 JP2002536438A5 JP2000598485A JP2000598485A JP2002536438A5 JP 2002536438 A5 JP2002536438 A5 JP 2002536438A5 JP 2000598485 A JP2000598485 A JP 2000598485A JP 2000598485 A JP2000598485 A JP 2000598485A JP 2002536438 A5 JP2002536438 A5 JP 2002536438A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- residue
- aryl
- cycloalkyl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 8
- 125000005915 C6-C14 aryl group Chemical group 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 125000000753 cycloalkyl group Chemical group 0.000 description 7
- 229910052736 halogen Inorganic materials 0.000 description 7
- 150000002367 halogens Chemical class 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 6
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 description 6
- -1 (C 1 -C 8 ) -alkoxy Chemical group 0.000 description 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 3
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000006386 Bone Resorption Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 102100022337 Integrin alpha-V Human genes 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 108010048673 Vitronectin Receptors Proteins 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000024279 bone resorption Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 1
- IXYNDHRYWPYGLR-UHFFFAOYSA-N CC1=CC=C(C=C1)S(=O)(=O)NC2=C(C=CC3=C2C(=C(C(=C3NS(=O)(=O)C4=CC=CC5=CC=CC=C54)NS(=O)(=O)C6=CC=C(C=C6)C(F)(F)F)NS(=O)(=O)C7=CC=C(C=C7)Br)NS(=O)(=O)C8=CC=C(C=C8)Cl)NS(=O)(=O)C9=CC=CC=C9 Chemical compound CC1=CC=C(C=C1)S(=O)(=O)NC2=C(C=CC3=C2C(=C(C(=C3NS(=O)(=O)C4=CC=CC5=CC=CC=C54)NS(=O)(=O)C6=CC=C(C=C6)C(F)(F)F)NS(=O)(=O)C7=CC=C(C=C7)Br)NS(=O)(=O)C8=CC=C(C=C8)Cl)NS(=O)(=O)C9=CC=CC=C9 IXYNDHRYWPYGLR-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99102916A EP1028114A1 (en) | 1999-02-13 | 1999-02-13 | Novel guanidine derivatives as inhibitors of cell adhesion |
| EP99102916.6 | 1999-02-13 | ||
| PCT/EP2000/000895 WO2000047564A1 (en) | 1999-02-13 | 2000-02-04 | Novel guanidine derivatives as inhibitors of cell adhesion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002536438A JP2002536438A (ja) | 2002-10-29 |
| JP2002536438A5 true JP2002536438A5 (enExample) | 2007-01-11 |
| JP4642242B2 JP4642242B2 (ja) | 2011-03-02 |
Family
ID=8237555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000598485A Expired - Lifetime JP4642242B2 (ja) | 1999-02-13 | 2000-02-04 | 細胞接着の阻害剤としての新規のグアニジン誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6340679B1 (enExample) |
| EP (2) | EP1028114A1 (enExample) |
| JP (1) | JP4642242B2 (enExample) |
| AT (1) | ATE273285T1 (enExample) |
| AU (1) | AU768206B2 (enExample) |
| CA (1) | CA2371789C (enExample) |
| DE (1) | DE60012890T2 (enExample) |
| ES (1) | ES2225086T3 (enExample) |
| IL (1) | IL144725A0 (enExample) |
| MX (1) | MXPA01008072A (enExample) |
| WO (1) | WO2000047564A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19629816A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
| US6972296B2 (en) | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| RS50470B (sr) | 1999-08-13 | 2010-03-02 | Biogen Idec Ma Inc. | Inhibitori ćelijske adhezije |
| KR101159061B1 (ko) | 2001-10-22 | 2012-06-22 | 더 스크립스 리서치 인스티튜트 | 항체 표적화 화합물 |
| DK1682537T3 (da) | 2003-11-05 | 2012-07-09 | Sarcode Bioscience Inc | Modulatorer af celleadhæsion |
| US7196112B2 (en) | 2004-07-16 | 2007-03-27 | Biogen Idec Ma Inc. | Cell adhesion inhibitors |
| EP2444079B1 (en) | 2005-05-17 | 2016-11-30 | SARcode Bioscience Inc. | Compositions and Methods for Treatment of Eye Disorders |
| JP2009512443A (ja) * | 2005-10-20 | 2009-03-26 | ザ スクリップス リサーチ インスチチュート | 免疫染色及び免疫標的化のためのＦｃ標識化 |
| CA2702984C (en) | 2007-10-19 | 2017-04-11 | Sarcode Corporation | Compositions and methods for treatment of diabetic retinopathy |
| US8080562B2 (en) * | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| CN102065893A (zh) * | 2008-04-15 | 2011-05-18 | 萨可德公司 | Lfa-1拮抗剂向胃肠系统的递送 |
| US20090257957A1 (en) * | 2008-04-15 | 2009-10-15 | John Burnier | Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders |
| CN102056485A (zh) * | 2008-04-15 | 2011-05-11 | 萨可德公司 | 用于局部治疗免疫相关疾病的局部lfa-1拮抗剂 |
| EP2395992A2 (en) | 2009-02-10 | 2011-12-21 | The Scripps Research Institute | Chemically programmed vaccination |
| WO2011050175A1 (en) | 2009-10-21 | 2011-04-28 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
| WO2014018748A1 (en) | 2012-07-25 | 2014-01-30 | Sarcode Bioscience Inc. | Lfa-1 inhibitor and polymorph thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204350A (en) | 1991-08-09 | 1993-04-20 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
| US5217994A (en) | 1991-08-09 | 1993-06-08 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
| US5250679A (en) | 1991-10-18 | 1993-10-05 | Genentech, Inc. | Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor |
| JP3322878B2 (ja) | 1992-10-14 | 2002-09-09 | メルク エンド カンパニー インコーポレーテッド | フィブリノーゲンレセプターアンタゴニスト |
| WO1994012181A1 (en) | 1992-12-01 | 1994-06-09 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| JPH10501222A (ja) | 1994-05-27 | 1998-02-03 | メルク エンド カンパニー インコーポレーテッド | 破骨細胞仲介骨吸収を抑制するための化合物 |
| PL318199A1 (en) | 1994-06-29 | 1997-05-26 | Smithkline Beecham Corp | Antagonists of vitronectin receptors |
| JPH10504807A (ja) | 1994-06-29 | 1998-05-12 | スミスクライン・ビーチャム・コーポレイション | ビトロネクチン受容体拮抗剤 |
| AU726793B2 (en) | 1995-08-14 | 2000-11-23 | Scripps Research Institute, The | Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis |
| DE19548709A1 (de) * | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosinderivate |
| KR20000022190A (ko) * | 1996-06-28 | 2000-04-25 | 플레믹 크리스티안 | 인테그린 저해제로서의 페닐알라닌 유도체 |
| DE19629816A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
| EP0933367A1 (en) * | 1997-12-19 | 1999-08-04 | Hoechst Marion Roussel Deutschland GmbH | Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists |
| HUP0100520A3 (en) | 1998-01-23 | 2002-11-28 | Genentech Inc | Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
-
1999
- 1999-02-13 EP EP99102916A patent/EP1028114A1/en not_active Withdrawn
-
2000
- 2000-02-04 WO PCT/EP2000/000895 patent/WO2000047564A1/en not_active Ceased
- 2000-02-04 ES ES00905022T patent/ES2225086T3/es not_active Expired - Lifetime
- 2000-02-04 EP EP00905022A patent/EP1155003B1/en not_active Expired - Lifetime
- 2000-02-04 MX MXPA01008072A patent/MXPA01008072A/es not_active IP Right Cessation
- 2000-02-04 CA CA002371789A patent/CA2371789C/en not_active Expired - Lifetime
- 2000-02-04 DE DE60012890T patent/DE60012890T2/de not_active Expired - Lifetime
- 2000-02-04 IL IL14472500A patent/IL144725A0/xx unknown
- 2000-02-04 AU AU26699/00A patent/AU768206B2/en not_active Ceased
- 2000-02-04 JP JP2000598485A patent/JP4642242B2/ja not_active Expired - Lifetime
- 2000-02-04 AT AT00905022T patent/ATE273285T1/de not_active IP Right Cessation
- 2000-02-11 US US09/502,577 patent/US6340679B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002536438A5 (enExample) | ||
| JP2001526271A5 (enExample) | ||
| JP2002501054A5 (enExample) | ||
| CA2326833C (en) | Indolyl-3-glyoxylic acid derivatives with antitumoral activity | |
| JP2002515500A5 (enExample) | ||
| HU229700B1 (en) | Calcium salt of (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl)sulfonyl]-(isobutyl)amino]-1-benzyl-2-(phosphonooxy) propylcarbamate, pharmaceutical composition containing the compound and process for preparation the same | |
| JP2011527334A5 (enExample) | ||
| JPWO2003099765A1 (ja) | β−アラニン誘導体およびその用途 | |
| JP2001509810A (ja) | Ｍｍｐインヒビターとしてのビス−スルホンアミドヒドロキサム酸 | |
| JP2003519137A (ja) | 抗腫瘍作用を有する置換されたｎ−ベンジル−インドール−３−イルグリオキシル酸誘導体 | |
| JP2022539126A (ja) | ベンゾジアゼピン系化合物及びその製造方法並びに医薬における作用 | |
| JPH02255652A (ja) | ベンゼンスルホンアミド類およびその製造方法 | |
| JP2005511594A5 (enExample) | ||
| EP1847533B1 (en) | Six-membered heterocyclic compound and the use thereof | |
| JP2003513066A5 (enExample) | ||
| JP2005516898A5 (enExample) | ||
| JP2003514859A5 (enExample) | ||
| RU2005105688A (ru) | Полиморфизм додекагидроциклопента (а) фенантренилового эфира тиофенкарбоновой кислоты | |
| WO2003024946A2 (en) | Oxamate derivatives containing a variously substituted nitrogen heterocycle | |
| ZA200704584B (en) | New 3-Phenylpropionic acid derivatives for the treatment of diabetes | |
| JP2002503721A5 (enExample) | ||
| JP2005515169A5 (enExample) | ||
| JP4280165B2 (ja) | 水溶性フェニルピリダジン誘導体及びこれを含有する医薬 | |
| KR20060127892A (ko) | 온단세트론의 신규한 다형 형태, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 항구토제로서의 이의 용도 | |
| JP2004505084A5 (enExample) |